betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment
- RxCUI
- 848180
- RxNorm name
- betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment
- Display name
- betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment
- Full name
- betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | b5291e39-40a0-4362-9281-97f5fb4025d9 | 2026-05-11 | Warnings, Adverse reactions | 848180 |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 853399f8-95a7-41f3-80e7-7ed8e3ff1a5e | 2026-01-30 | Warnings, Adverse reactions | 848180 |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Prasco Laboratories | f5b50c00-cc6f-4296-a9ae-b16888cef4dd | 2025-11-19 | Warnings, Adverse reactions | 848180 |
| DIPROLENE | BETAMETHASONE DIPROPIONATE | Organon LLC | 0b9543ad-2ca7-430d-aef9-81c376dc2e6c | 2025-11-19 | Warnings, Adverse reactions | 848180 |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Lupin Pharmaceuticals, Inc. | 216d5b7f-4236-4882-b899-be17cb1a1584 | 2025-11-13 | Warnings, Adverse reactions | 848180 |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | 018fcec3-bfb4-451c-9b54-d1fd389c2a44 | 2025-03-14 | Warnings, Adverse reactions | 848180 |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Burel Pharmaceuticals, LLC | c8bda9a8-4dec-4084-84e5-4b4623390bd8 | 2024-12-04 | Warnings, Adverse reactions | 848180 |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Aurobindo Pharma Limited | e0e0baea-1744-4708-bda7-4ab7783a3fb4 | 2024-06-05 | Warnings, Adverse reactions | 848180 |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Actavis Pharma, Inc. | af8317d7-b280-4f40-ad88-802f99d33d78 | 2023-02-14 | Warnings, Adverse reactions | 848180 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| af8317d7-b280-4f40-ad88-802f99d33d78 | betamethasone dipropionate 0.05 % Augmented Topical Ointment [PSN] · Augmented betamethasone 0.0005 MG/MG Topical Ointment [SCD] · augmented betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.05 % Augmented Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment [SY] | 5 | 21 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE OINTMENT (augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE OINTMENT (augmented). BETAMETHASONE DIPROPIONATE ointment (augmented) 0.05% for topical use Initial U.S. Approval: 1983 | 20230214 |
| 853399f8-95a7-41f3-80e7-7ed8e3ff1a5e | betamethasone dipropionate 0.05 % Augmented Topical Ointment [PSN] · Augmented betamethasone 0.0005 MG/MG Topical Ointment [SCD] · augmented betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.05 % Augmented Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment [SY] | 5 | 13 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Ointment (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Ointment (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE ointment (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 | 20260130 |
| f5b50c00-cc6f-4296-a9ae-b16888cef4dd | betamethasone dipropionate 0.05 % Augmented Topical Ointment [PSN] · Augmented betamethasone 0.0005 MG/MG Topical Ointment [SCD] · augmented betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.05 % Augmented Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment [SY] | 5 | 12 | These highlights do not include all the information needed to use Augmented Betamethasone Dipropionate Ointment safely and effectively. See full prescribing information for Augmented Betamethasone Dipropionate Ointment. Augmented Betamethasone Dipropionate ointment, for topical use Initial U.S. Approval: 1983 | 20251119 |
| 216d5b7f-4236-4882-b899-be17cb1a1584 | betamethasone dipropionate 0.05 % Augmented Topical Ointment [PSN] · Augmented betamethasone 0.0005 MG/MG Topical Ointment [SCD] · augmented betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.05 % Augmented Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment [SY] | 5 | 9 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE OINTMENT USP (AUGMENTED) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE OINTMENT USP (AUGMENTED). BETAMETHASONE DIPROPIONATE ointment USP (Augmented), for topical use Initial U.S. Approval: 1983 | 20251113 |
| b1c3c530-6e28-4fba-9a9d-5fac9819e3e6 | betamethasone dipropionate 0.05 % Augmented Topical Ointment [PSN] · Augmented betamethasone 0.0005 MG/MG Topical Ointment [SCD] · augmented betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.05 % Augmented Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment [SY] | 5 | 5 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Ointment safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Ointment. BETAMETHASONE DIPROPIONATE Ointment USP, (Augmented) 0.05% for topical use Initial U.S. Approval: 1983 | 20180717 |
| b5291e39-40a0-4362-9281-97f5fb4025d9 | betamethasone dipropionate 0.05 % Augmented Topical Ointment [PSN] · Augmented betamethasone 0.0005 MG/MG Topical Ointment [SCD] · augmented betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.05 % Augmented Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment [SY] | 5 | 3 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE OINTMENT USP (AUGMENTED) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE OINTMENT USP (AUGMENTED). BETAMETHASONE DIPROPIONATE ointment USP (Augmented), for topical use Initial U.S. Approval: 1983 | 20260511 |
| 0b9543ad-2ca7-430d-aef9-81c376dc2e6c | betamethasone dipropionate 0.05 % Augmented Topical Ointment [PSN] · Augmented betamethasone 0.0005 MG/MG Topical Ointment [SCD] · augmented betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.05 % Augmented Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment [SY] | 5 | 3 | These highlights do not include all the information needed to use DIPROLENE Ointment safely and effectively. See full prescribing information for DIPROLENE Ointment. DIPROLENE ® (augmented betamethasone dipropionate) ointment, for topical use Initial U.S. Approval: 1983 | 20251119 |
| e0e0baea-1744-4708-bda7-4ab7783a3fb4 | betamethasone dipropionate 0.05 % Augmented Topical Ointment [PSN] · Augmented betamethasone 0.0005 MG/MG Topical Ointment [SCD] · augmented betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.05 % Augmented Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment [SY] | 5 | 3 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE OINTMENT (AUGMENTED) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE OINTMENT (AUGMENTED). BETAMETHASONE DIPROPIONATE ointment (augmented), for topical use Initial U.S. Approval: 1983 | 20240605 |
| 018fcec3-bfb4-451c-9b54-d1fd389c2a44 | betamethasone dipropionate 0.05 % Augmented Topical Ointment [PSN] · Augmented betamethasone 0.0005 MG/MG Topical Ointment [SCD] · augmented betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.05 % Augmented Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment [SY] | 5 | 1 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Ointment (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Ointment (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE ointment (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 | 20250314 |
| c8bda9a8-4dec-4084-84e5-4b4623390bd8 | betamethasone dipropionate 0.05 % Augmented Topical Ointment [PSN] · Augmented betamethasone 0.0005 MG/MG Topical Ointment [SCD] · augmented betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.05 % Augmented Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment [SY] | 5 | 1 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE OINTMENT (AUGMENTED) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE OINTMENT (AUGMENTED). BETAMETHASONE DIPROPIONATE ointment (augmented), for topical use Initial U.S. Approval: 1983 | 20241204 |
| 686b528e-5480-4caa-8ff4-b1baaf5983ec | betamethasone dipropionate 0.05 % Augmented Topical Ointment [PSN] · Augmented betamethasone 0.0005 MG/MG Topical Ointment [SCD] · augmented betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.05 % Augmented Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Augmented Topical Ointment [SY] | 5 | 1 | Augmented Betamethasone Dipropionate Vehicle augments the penetration of the steroid. Ointment 0.05% (potency expressed as betamethasone) | 20061207 |